DEA Updated Drugs of Abuse Report
The 2026 report reflects federal rescheduling of medical cannabis and tracks emergency room visit trends.
Updated on Oct. 5, 2026 in Substance Abuse
Live Poll
Should marijuana be reclassified as a less dangerous substance under federal law?
The Drug Enforcement Administration released its updated 119-page Drugs of Abuse report in 2026. The document acknowledges the federal shift of state-licensed medical marijuana to Schedule III.
Why it matters
The report was revised to align federal documentation with recent changes in state medical marijuana laws and federal rescheduling actions. This update provides clarity on how the government now classifies specific medical cannabis products.
The 119-page DEA report confirms that no deaths from marijuana overdose have been reported, representing a status update against historical data collected over three decades of state-level legalization.
The players
Drug Enforcement Administration
The federal agency responsible for enforcing controlled substances laws and issuing reports on drug trends.
Todd Blanche
The Attorney General of the United States who announced the rescheduling of medical marijuana in April 2026.
The details
The report incorporates the April 2026 move by Attorney General Todd Blanche to transition state-licensed medical cannabis into the Schedule III category. While the report formally classifies these products, it cautions that marijuana use can impair learning and psychomotor behavior. It also highlights a rise in emergency room visits associated with the consumption of marijuana edibles.
Timeline
In April 2026, the Attorney General moved medical marijuana to Schedule III.
The previous Drugs of Abuse report was published in 2024.
The updated Drugs of Abuse report was released in 2026.
Health Landscape
This report represents a significant pivot in federal policy under the Controlled Substances Act by acknowledging the evolving state-level legal landscape. It moves medical cannabis into a new classification while maintaining federal oversight of its public health impact.
Readers should be aware that marijuana, including edibles, continues to be associated with risks like psychomotor impairment and increased emergency room visits. If you are using medical cannabis, consider discussing the implications of these health cautions with your physician.
The takeaway
While federal rescheduling for medical marijuana has occurred, health agencies continue to warn of risks regarding impairment and edible safety. Pay close attention to how state-level legal changes interact with federal guidelines when considering treatment options.
Further reading
For more on evolving drug policies, visit our Substance Abuse section.
Source note: This article includes information reported by Marijuana Moment.
Live Poll
Should marijuana be reclassified as a less dangerous substance under federal law?
